New DEA Data Indicates Florida Received Nearly 80% of First Federal Medical Marijuana Dispensary Registrations

Florida appears to have accounted for nearly 80% of the medical marijuana dispensary applications removed from the Drug Enforcement Administration’s (DEA) public applicant list following the agency’s first round of federal registrations, according to an examination of newly updated federal records.

The DEA’s official list, updated November 1, shows that Florida’s pending medical marijuana dispensary applications declined from 748 on October 30 to just 44, a reduction of 704 entries in two days. That represents a 94.1% reduction in the state’s pending dispensary applications and accounts for 78.3% of all dispensary entries removed nationwide during that period.

The figures follow the Justice Department’s October 30 announcement that more than 900 medical marijuana dispensaries across seven states had received federal registrations under President Trump’s partial marijuana rescheduling order.

Although the department identified Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia as the states receiving registrations, it did not disclose how many businesses were approved in each state.

The updated DEA records provide the clearest indication yet of how those initial registrations may have been distributed. Nationwide, the number of pending dispensary applications declined from 4,197 to 3,298, a reduction of 899. Every one of those reductions occurred in the seven states identified in the Justice Department’s announcement.

Florida’s reduction of 704 was substantially larger than that of any other state. Mississippi recorded the second-largest decline, falling from 97 pending dispensary applications to 20, a reduction of 77. West Virginia’s 48 dispensary entries disappeared entirely, while South Dakota declined from 43 to one.

Virginia also saw all 24 of its dispensary entries removed. Texas declined from four to one, while Alabama’s single pending dispensary entry was removed.

The timing and geographic distribution strongly suggest that the changes are connected to the DEA’s initial federal registrations. However, the agency’s applicant list does not identify approved businesses or explain why individual entries were removed. The DEA states that applicants may disappear from the list after receiving registration, withdrawing their applications or otherwise losing their status as timely applicants.

Consequently, the records do not conclusively establish that all 704 Florida dispensary entries removed received federal registration. The Justice Department’s announcement of more than 900 registrations also slightly exceeds the 899 dispensary entries removed from the public list, indicating that the two figures should not be treated as identical measures.

Still, the concentration of removals in Florida is notable, particularly given the state’s position as one of the country’s largest medical marijuana markets. Florida operates a vertically integrated system in which licensed medical marijuana treatment centers are responsible for cultivation, processing and retail distribution.

The updated federal records show that Florida now has 108 total applications remaining on the DEA’s timely applicant list, including 44 dispensaries, 45 manufacturers and 19 distributors. On October 30, the state had 812 entries, making it the second-largest source of applications nationwide.

Across the country, the DEA’s list has declined from 6,983 entries on October 30 to 6,083 on November 1. The updated total includes 3,298 dispensary applications, 2,075 manufacturer applications and 710 distributor applications. Aside from the 899 dispensary entries removed, the only other reduction was a single manufacturer application in Colorado.

Oklahoma now accounts for the largest share of remaining applications, with 2,442 entries, representing approximately 40% of the nationwide total. California follows with 771, while Maine has 320 and Pennsylvania has 227.

The federal registration process was established under the Trump administration’s April marijuana rescheduling order, which moved qualifying state-licensed medical marijuana activities into Schedule III while leaving recreational marijuana and other activities outside the order under Schedule I.

Businesses that applied during the initial 60-day registration window were eligible for expedited consideration and were allowed to continue qualifying medical marijuana operations under their state licenses while awaiting federal approval.

According to the Justice Department, the first dispensaries receiving federal registration successfully completed DEA investigations and satisfied applicable regulatory requirements. Registered businesses must comply with federal security, recordkeeping, inventory and other controlled-substance requirements.

The DEA says additional dispensary registrations will be issued through a phased process, while applications from manufacturers and distributors remain under review. The agency’s public applicant list is scheduled to be updated daily, potentially providing further insight into how federal registrations are being distributed as the process continues.